Insider Trading activities of Aquinox Pharmaceuticals, Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aquinox Pharmaceuticals, Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aquinox Pharmaceuticals, Inc since year 2005. Table 2 shows the detailed insider transactions of Aquinox Pharmaceuticals, Inc since 2005. The reporting company's ticker symbol is AQXP. The reporting company's CIK number is 1404644.
The total value of stock buying since 2005 is $91,647,410.
The total value of stock sales since 2005 is $43,663,757.
The total value of stock option exercises since 2005 is $524,204.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aquinox Pharmaceuticals, Inc (AQXP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 0 $0 15,625 $207,243 15,625 $150,000
2017-01 398,062 $6,483,633 0 $0 0 $0
2016-09 2,783,605 $34,934,242 0 $0 0 $0
2016-03 471,667 $3,739,481 0 $0 0 $0
2016-01 533,488 $4,946,915 0 $0 0 $0
2015-09 2,480,032 $38,440,496 0 $0 0 $0
2015-08 5,175 $102,646 1,839,714 $43,067,887 64,966 $374,204
2014-12 0 $0 38,500 $295,796 0 $0
2014-11 0 $0 11,500 $92,831 0 $0
2014-03 272,727 $2,999,997 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Aquinox Pharmaceuticals, Inc insiders (AQXP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-05 Main David (President and CEO) Sale 3,625 13.16 47,697
2017-06-05 Main David (President and CEO) Option Ex 3,625 9.60 34,800
2017-06-02 Main David (President and CEO) Sale 6,000 13.59 81,558
2017-06-02 Main David (President and CEO) Option Ex 6,000 9.60 57,600
2017-06-01 Main David (President and CEO) Sale 6,000 13.00 77,988
2017-06-01 Main David (President and CEO) Option Ex 6,000 9.60 57,600
2017-01-09 Baker Julian (10% Owner) Buy 398,062 16.29 6,483,633
2016-09-20 Baker Julian (10% Owner) Buy 2,783,605 12.55 34,934,242
2016-03-16 Baker Julian (10% Owner) Buy 361,755 7.92 2,865,461
2016-03-15 Baker Julian (10% Owner) Buy 109,912 7.95 874,020
2016-01-26 Baker Julian (10% Owner) Buy 77,639 10.90 846,265
2016-01-25 Baker Julian (10% Owner) Buy 10,945 11.14 121,894
2016-01-22 Baker Julian (10% Owner) Buy 52,202 10.69 558,091
2016-01-20 Baker Julian (10% Owner) Buy 112,034 9.18 1,027,911
2016-01-19 Baker Julian (10% Owner) Buy 78,045 9.15 713,955
2016-01-15 Baker Julian (10% Owner) Buy 84,670 8.61 728,924
2016-01-14 Baker Julian (10% Owner) Buy 117,953 8.05 949,875
2015-09-10 Baker Julian (10% Owner) Buy 2,480,032 15.50 38,440,496
2015-08-24 Mitchell David Chilton (VP Global Regulatory & Quality) Buy 3,575 17.81 63,670
2015-08-12 Mackenzie Lloyd (VP Technical Operations) Sale 35,887 18.67 670,010
2015-08-12 Mackenzie Lloyd (VP Technical Operations) Option Ex 35,887 5.76 206,709
2015-08-12 Alam Kamran (CFO, Vice President Finance) Sale 29,079 18.67 542,904
2015-08-12 Alam Kamran (CFO, Vice President Finance) Option Ex 29,079 5.76 167,495
2015-08-11 Mitchell David Chilton (VP Global Regulatory & Quality) Buy 1,600 24.36 38,976
2015-08-11 Johnson & Johnson Innovation - Jjdc, Inc. (10% Owner) Sale 1,283,366 20.74 26,617,010
2015-08-10 Johnson & Johnson Innovation - Jjdc, Inc. (10% Owner) Sale 231,455 31.66 7,327,865
2015-08-10 Pfizer Inc (10% Owner) Sale 259,927 30.43 7,910,098
2014-12-17 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 1,593 7.58 12,074
2014-12-16 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 6,507 7.63 49,648
2014-12-12 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 3,645 7.51 27,373
2014-12-11 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 1,355 7.50 10,162
2014-12-10 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 1,300 7.70 10,010
2014-12-09 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 5,000 7.73 38,650
2014-12-08 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 2,000 7.69 15,380
2014-12-05 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 4,200 7.78 32,676
2014-12-04 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 10,073 7.76 78,166
2014-12-03 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 1,627 7.75 12,609
2014-12-01 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 1,200 7.54 9,048
2014-11-26 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 500 7.60 3,800
2014-11-25 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 1,500 7.80 11,700
2014-11-24 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 4,000 8.02 32,080
2014-11-21 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 2,400 8.25 19,800
2014-11-20 Johnson & Johnson Development Corp Et Al (10% Owner) Sale 3,100 8.21 25,451
2014-03-12 Pfizer Inc (10% Owner) Buy 272,727 11.00 2,999,997

Insider trading activities including stock purchases, stock sales, and option exercises of AQXP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aquinox Pharmaceuticals, Inc (symbol AQXP, CIK number 1404644) see the Securities and Exchange Commission (SEC) website.